FDA
-
-
-
-
-
-
-
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
-
-
-
-
-
-
-
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
-
-
-
-
-
-
-
Cardiff Oncology (CRDF) Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
-
-
-
-
-
-
-
Cardiff Oncology (CRDF) Prices Oversubscribed $40 Million Underwritten Registered Direct Offering
-
-
-
-
-
-
-
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC
-
-
-
-
-
-
-
Cardiff Oncology (CRDF) Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research
-
-
-
-
-
-
-
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

